Time-kill studies investigating the killing activity of caspofungin against Candida dubliniensis: comparing RPMI-1640 and antibiotic medium 3 (original) (raw)

Characterizing the Effects of Caspofungin on Candida albicans, Candida parapsilosis, and Candida glabrata Isolates by Simultaneous Time-Kill and Postantifungal-Effect Experiments

Hartmut Derendorf

Antimicrobial Agents and Chemotherapy, 2006

View PDFchevron_right

Comparison of killing activity of caspofungin against Candida parapsilosis, Candida orthopsilosis and Candida metapsilosis

Laszlo Majoros

Journal of Antimicrobial Chemotherapy, 2008

View PDFchevron_right

Killing rates for caspofungin against Candida albicans after brief and continuous caspofungin exposure in the presence and absence of serum

Laszlo Majoros

Mycopathologia, 2014

View PDFchevron_right

Killing rates exerted by caspofungin in 50 % serum and its correlation with in vivo efficacy in a neutropenic murine model against Candida krusei and Candida inconspicua

Rudolf Gesztelyi

Journal of Medical Microbiology, 2014

View PDFchevron_right

Caspofungin Susceptibility Testing of Candida inconspicua : Correlation of Different Methods with the Minimal Fungicidal Concentration

Matthias Sipiczki

Antimicrobial Agents and Chemotherapy, 2005

View PDFchevron_right

Caspofungin Susceptibility Testing of Candida inconspicua: Correlation of Different Methods with the Minimal Fungicidal Concentration

Laszlo Majoros

Antimicrobial Agents and Chemotherapy, 2005

View PDFchevron_right

Dose escalation studies with caspofungin against Candida glabrata

Laszlo Majoros

Journal of Medical Microbiology, 2015

View PDFchevron_right

Effects of Caspofungin against Candida guilliermondii and Candida parapsilosis

Elisabetta Spreghini

Antimicrobial Agents and Chemotherapy, 2006

View PDFchevron_right

In Vitro Study of Candida tropicalis Isolates Exhibiting Paradoxical Growth in the Presence of High Concentrations of Caspofungin

Rudolf Gesztelyi

Antimicrobial Agents and Chemotherapy, 2007

View PDFchevron_right

Interlaboratory comparison of results of susceptibility testing with caspofungin against Candida and Aspergillus species

Roberto Andrade

Journal of Clinical Microbiology, 2004

View PDFchevron_right

Comparative In Vitro Activities of Caspofungin and Micafungin, Determined Using the Method of the European Committee on Antimicrobial Susceptibility Testing, against Yeast Isolates Obtained in France in 2005-2006

Eric Dannaoui

Antimicrobial Agents and Chemotherapy, 2008

View PDFchevron_right

Efficacy of humanized single large doses of caspofungin on the lethality and fungal tissue burden in a deeply neutropenic murine model against Candida albicans and Candida dubliniensis

Lajos Forgács

Infection and Drug Resistance

View PDFchevron_right

Cellular apoptosis: An alternative mechanism of action for caspofungin against Candida glabrata

Tahereh Shokohi

Current Medical Mycology

View PDFchevron_right

Efficacy of Caspofungin against Aspergillus terreus

Elisabetta Spreghini

Antimicrobial Agents and Chemotherapy, 2005

View PDFchevron_right

In Vitro Activities of Caspofungin Compared with Those of Fluconazole and Itraconazole against 3,959 Clinical Isolates of Candida spp., Including 157 Fluconazole-Resistant Isolates

Ronald Jones

Antimicrobial Agents and Chemotherapy, 2003

View PDFchevron_right

Comparative Effects of Micafungin, Caspofungin, and Anidulafungin against a Difficult-To-Treat Fungal Opportunistic Pathogen, Candida glabrata

E. Manso

Antimicrobial Agents and Chemotherapy, 2012

View PDFchevron_right

Killing kinetics of caspofungin, micafungin, and amphotericin B against Candida guilliermondii

Macrina Sastre, Emilia Canton

Antimicrobial agents and chemotherapy, 2006

View PDFchevron_right

In vitroactivity of caspofungin compared to amphotericin B, fluconazole, and itraconazole againstCandidastrains isolated in a Turkish University Hospital

Banu Sancak

Medical Mycology, 2005

View PDFchevron_right

Comparison between Disk Diffusion and Microdilution Methods for Determining Susceptibility of Clinical Fungal Isolates to Caspofungin

Elisabetta Spreghini

Journal of Clinical Microbiology, 2007

View PDFchevron_right

Caspofungin in Combination with Amphotericin B against Candida glabrata

Elisabetta Spreghini

Antimicrobial Agents and Chemotherapy, 2005

View PDFchevron_right

Comparative In Vitro Pharmacodynamics of Caspofungin, Micafungin, and Anidulafungin against Germinated and Nongerminated Aspergillus Conidia

Thomas Walsh

Antimicrobial Agents and Chemotherapy, 2008

View PDFchevron_right

The Effects of Treated vs. Untreated Polystyrene on Caspofungin In Vitro Activity against Candida Species

Mohammad Albataineh

Journal of Clinical Microbiology, 2016

View PDFchevron_right

Concentration-Dependent Effects of Caspofungin on the Metabolic Activity of Aspergillus Species

Thomas Walsh

Antimicrobial Agents and Chemotherapy, 2007

View PDFchevron_right

In Vivo Efficacy of Anidulafungin and Caspofungin against Candida glabrata and Association with In Vitro Potency in the Presence of Sera

Laura Najvar

Antimicrobial Agents and Chemotherapy, 2007

View PDFchevron_right

Relative Frequency of Paradoxical Growth and Trailing Effect with Caspofungin, Micafungin, Anidulafungin, and the Novel Echinocandin Rezafungin against Candida Species

Lajos Forgács

Journal of Fungi

View PDFchevron_right